You have 9 free searches left this month | for more free features.

SARS-CoV virus

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Sars-CoV-2 Infection Trial in Negrar (Nasal and mouth swab)

Active, not recruiting
  • Sars-CoV-2 Infection
  • Nasal and mouth swab
  • Negrar, Verona, Italy
    IRCCS Sacro Cuore Don Calabria hospital
Mar 14, 2023

SARS-CoV-2 Virus Trial in Bangkok (SARS-CoV-2 RNA detection)

Completed
  • SARS-CoV-2 Virus
  • SARS-CoV-2 RNA detection
  • Bangkok, Thailand
    2 Division of Nephrology,Department of Medicine Pramongkutklao H
Aug 31, 2023

Respiratory Viral Infection Trial (SARS-COV-2, Influenza and RSV 8-Well MT-PCR Panel, BioFire Respiratory Panel 2.1)

Not yet recruiting
  • Respiratory Viral Infection
  • SARS-COV-2, Influenza and RSV 8-Well MT-PCR Panel
  • BioFire Respiratory Panel 2.1
  • (no location specified)
Jul 13, 2023

Influenza A, Influenza Type B, SARS CoV 2 Infection Trial in Raleigh (Diagnostic Test for identification of influenzas A,

Not yet recruiting
  • Influenza A
  • +3 more
  • Diagnostic Test for identification of influenzas A, influenzas B, RSV and SARS-CoV-2 infections
  • Raleigh, North Carolina
    Wake Med
Jun 26, 2023

SARS-CoV-2 Infection Trial in Germany, United States (PRIME-2-CoV_Beta)

Recruiting
  • SARS-CoV-2 Infection
  • Florida City, Florida
  • +6 more
Jan 31, 2023

Coronavirus Trial in Oxford (SARS-CoV-2 virus)

Recruiting
  • Coronavirus
  • SARS-CoV-2 virus
  • Oxford, Oxon, United Kingdom
  • +2 more
Jan 5, 2023

Sars-CoV-2 Infection, COVID-19 Trial in Knoxville (Rapid SARS-CoV-2 Antigen Test)

Completed
  • Sars-CoV-2 Infection
  • COVID-19
  • Rapid SARS-CoV-2 Antigen Test
  • Knoxville, Tennessee
    EDP Biotech Corporation
Oct 14, 2022

ME/CFS, SARS CoV 2 Infection, Fatigue Syndrome, Chronic Trial in München

Recruiting
  • ME/CFS
  • +3 more
    • München, Germany
      München Klinik Schwabing
    Mar 20, 2023

    SARS-CoV Infection, Coronavirus, Corona Virus Infection Trial in Copenhagen (An Oropharyngeal swab)

    Recruiting
    • SARS-CoV Infection
    • +2 more
    • An Oropharyngeal swab
    • Copenhagen, Hillerød, Denmark
    • +1 more
    Jan 10, 2023

    A Wearable, Battery-free Screening System for SARS-CoV-2, Virus

    Terminated
    • Covid19
      • Omaha, Nebraska
        University of Nebraska Medical Center
      Nov 9, 2022

      COVID-19 Trial (GamCoviMab)

      Not yet recruiting
      • COVID-19
      • (no location specified)
      Feb 6, 2023

      Against Sars-Cov2 Virus in Received EU-approved COVID-19

      Completed
      • SARS-CoV2 Infection
      • Vaccine Reaction
      • Approved vaccines against Sars-Cov2
      • Patras, Greece
        University Hospital of Patras
      Jun 2, 2022

      SARS-CoV-2/COVID-19 Study of Next Generation Non-Invasive

      Not yet recruiting
      • COVID-19
      • +5 more
      • imPulse™ Una infrasound-to-ultrasound e-stethoscope
      • (no location specified)
      Mar 9, 2023

      Influenza, COVID-19, RSV Infection Trial (Collection of saliva, nasopharyngeal-, nasal-, and oropharyngeal swabs)

      Not yet recruiting
      • Influenza
      • +2 more
      • Collection of saliva, nasopharyngeal-, nasal-, and oropharyngeal swabs
      • (no location specified)
      Mar 1, 2023

      SARS-COV2 Pandemic Serosurvey in a Rare Disease Population

      Completed
      • SARS-COV2 Virus
        • Bethesda, Maryland
        • +1 more
        Dec 16, 2022

        Infectious Viral Load: a Prospective Observational Study

        Recruiting
        • SARS-CoV-2 Infection
        • +3 more
        • No intervention
        • Geneva, Switzerland
          Geneva University Hospital
        Mar 20, 2023

        Covid19, SARS-CoV Infection, Corona Virus Infection Trial in London (SARS-CoV-2 Virus, Remdesivir)

        Completed
        • Covid19
        • +4 more
        • London, United Kingdom
        • +1 more
        Jul 27, 2022

        COVID-19 Vaccine Trial in Ciudad Autónoma de Buenos Aires (ARVAC-CG vaccine (recombinant protein vaccine against SARS-CoV-2))

        Active, not recruiting
        • COVID-19 Vaccine
        • ARVAC-CG vaccine (recombinant protein vaccine against SARS-CoV-2)
        • Ciudad Autónoma de Buenos Aires, Argentina
          Unidad de Investigación Clínica Farmacocinética FP Clinical Phar
        Dec 21, 2022

        SARS-CoV-2 Infection Trial in Baltimore (B/HPIV3/S-6P)

        Recruiting
        • SARS-CoV-2 Infection
        • B/HPIV3/S-6P
        • Baltimore, Maryland
          Johns Hopkins Bloomberg School of Public Health
        Aug 30, 2023

        SARS CoV-2 Virus Secretions and Serum for Countermeasure

        Recruiting
        • Covid19
          • New Orleans, Louisiana
          • +1 more
          Jul 19, 2022

          COVID-19 Trial in United States (Hemopurifier)

          Terminated
          • COVID-19
          • Hemopurifier
          • Irvine, California
          • +8 more
          Dec 16, 2022

          SARS-CoV-2 Infection, COVID-19 Trial in Anaheim, Knoxville (iCura COVID-19 Antigen Rapid Home Test, RT-PCR Test)

          Recruiting
          • SARS-CoV-2 Infection
          • COVID-19
          • iCura COVID-19 Antigen Rapid Home Test
          • RT-PCR Test
          • Anaheim, California
          • +1 more
          Sep 23, 2022

          SARS-CoV2 Infection, COVID-19 Trial in United States (iCura COVID-19 Antigen Rapid Home Test, RT-PCR Test)

          Completed
          • SARS-CoV2 Infection
          • COVID-19
          • iCura COVID-19 Antigen Rapid Home Test
          • RT-PCR Test
          • DeLand, Florida
          • +3 more
          Oct 14, 2022

          Covid19 Trial in Lenexa, Raleigh (Investigational vaccine against SARS-CoV-2 [MV-014-212] Dosage 1, Single Dose, Intranasal

          Recruiting
          • Covid19
          • Investigational vaccine against SARS-CoV-2 [MV-014-212] Dosage 1, Single Dose, Intranasal Drops
          • +4 more
          • Lenexa, Kansas
          • +1 more
          Aug 1, 2022

          SARS-COV2 Pandemic Serosurvey and Blood Sampling

          Completed
          • SARS-COV2 Virus
            • Birmingham, Alabama
            • +2 more
            Jul 6, 2022